Your browser doesn't support javascript.
loading
Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
Andreani, Lorenzo; Ipponi, Edoardo; Ruinato, Alfio Damiano; Lupi, Tommaso; Di Sacco, Federico; Volterrani, Duccio; Coccoli, Luca; Capanna, Rodolfo.
Affiliation
  • Andreani L; University of Pisa, Pisa, Italy.
  • Ipponi E; University of Pisa, Pisa, Italy.
  • Ruinato AD; University of Pisa, Pisa, Italy.
  • Lupi T; University of Pisa, Pisa, Italy.
  • Di Sacco F; University of Pisa, Pisa, Italy.
  • Volterrani D; University of Pisa, Pisa, Italy.
  • Coccoli L; University of Pisa, Pisa, Italy.
  • Capanna R; University of Pisa, Pisa, Italy.
Folia Med (Plovdiv) ; 66(2): 196-202, 2024 Apr 30.
Article in En | MEDLINE | ID: mdl-38690814
ABSTRACT

INTRODUCTION:

Osteosarcoma (OS) and Ewing sarcoma (ES) represent the pediatric population's most common malignant bone tumors. 18-Fluorodeoxyglucose positron emission tomography has been shown to be effective in both the diagnostic and staging phases of cancer treatment. In recent years, some studies have also explored the possibility that FDG-PET could have a prognostic role.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Ewing / Bone Neoplasms / Osteosarcoma / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography Limits: Humans Language: En Journal: Folia Med (Plovdiv) Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Bulgaria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Ewing / Bone Neoplasms / Osteosarcoma / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography Limits: Humans Language: En Journal: Folia Med (Plovdiv) Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Bulgaria